title: Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
abstract: Comprehensive catalogue of genes that drive tumor initiation and progression in cancer is key to advancing diagnostics, therapeutics and treatment. Given the complexity of cancer, the catalogue is far from complete yet. Increasing evidence shows that driver genes exhibit consistent aberration patterns across multiple-omics in tumors. In this study, we aim to leverage complementary information encoded in each of the omics data to identify novel driver genes through an integrative framework. Specifically, we integrated mutations, gene expression, DNA copy numbers, DNA methylation and protein abundance, all available in The Cancer Genome Atlas (TCGA) and developed iDriver, a non-parametric Bayesian framework based on multivariate statistical modeling to identify driver genes in an unsupervised fashion. iDriver captures the inherent clusters of gene aberrations and constructs the background distribution that is used to assess and calibrate the confidence of driver genes identified through multi-dimensional genomic data.
  
  
  
  We applied the method to 4 cancer types in TCGA and identified candidate driver genes that are highly enriched with known drivers. (e.g.: P < 3.40 × 10 -36 for breast cancer). We are particularly interested in novel genes and observed multiple lines of supporting evidence. Using systematic evaluation from multiple independent aspects, we identified 45 candidate driver genes that were not previously known across these 4 cancer types. The finding has important implications that integrating additional genomic data with multivariate statistics can help identify cancer drivers and guide the next stage of cancer genomics research.
  
  
  
  The C ++ source code is freely available at https://medschool.vanderbilt.edu/cgg/ .
  
  
  
  hai.yang@vanderbilt.edu or bingshan.li@Vanderbilt.Edu.
  
  
  
  Supplementary data are available at Bioinformatics online.
authors: Department of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.|Vanderbilt Genetics Institute, Nashville, TN, USA.
authors: Hai
authors: H
authors: Yang
authors: Department of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.|Vanderbilt Genetics Institute, Nashville, TN, USA.
authors: Qiang
authors: Q
authors: Wei
authors: Vanderbilt Genetics Institute, Nashville, TN, USA.|Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
authors: Xue
authors: X
authors: Zhong
authors: Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
authors: Hushan
authors: H
authors: Yang
authors: Department of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.|Vanderbilt Genetics Institute, Nashville, TN, USA.
authors: Bingshan
authors: B
authors: Li
mesh_terms: D001499:Bayes Theorem; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D019175:DNA Methylation; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D052138:Genes, Neoplasm; D023281:Genomics / Q000379:methods*; D006801:Humans; D015233:Models, Statistical; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology; D012984:Software